Senior insider sale
TRAVERE THERAPEUTICS, INC. — senior position signals high conviction
$629.7K
18K shares
What this filing means
COUGHLIN TIMOTHY plans to sell 18K shares of TRAVERE THERAPEUTICS, INC. valued at approximately $629.7K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/31/2025ACC: 0001957799-25-000224
Director
Since May 2019
18K
Shares to sell
$629.7K
Approx. market value
18K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
NSOs
10/31/2025
10/31/2025
18KTotal acquired18K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/31/2025 | NSOs 10/31/2025 | 18K | — |
| Total | 18K | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
18K
Market value
$629.7K
10/31/2025
Total
Units
18K
Value
$629.7K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
10/31/2025 | 18K | $629.7K | Nasdaq | Planned |
| Total | 18K | $629.7K | ||